GYNOCARE building bridges with Pharma and Biotech
During the Training School organised in Sofia, Bulgaria in June 2023, one of the workshops was specifically dedicated to robotic surgery and its role in operating on patients with rare gynaecological cancer. This was organised by Dr Mariela Vasileva-Slaveva. The national media in Bulgaria covered this even in a press release. Click here to read more.
Dr Karina Belemezova from Sofia University gave a practical workshop on HPV testing in collaboration with a biotech company.
In addition, during the same meeting, there was a series of lectures dedicated to advances in robotic surgery in the field of gynae-oncology. Click here to read more.
Collaboration with Pharma Companies
Collaboration with pharma companies helped to support our early stage career researchers. One example is Gedeon Richter plc, which is a European innovation-driven specialty pharmaceutical company with products distributed in more than 100 countries worldwide. The Gedeon Richter prize includes a monetary prize and a book token for the medical student whose women’s health related essay submission is deemed to be the most meritorious by a board of assessors representing the departments of obstetrics and gynaecology and of the pre-clinical studies. Mr Karl Livori was awarded this prize in 2023, following his essay on ‘Endometriosis-associated Ovarian Cancer’ , done in collaboration with GYNOCARE members.
There was an exhibition area set up specifically organized by pharma companies at GYNOCARE conferences, and conferences organized by GYNOCARE members.
